United States · FDA National Drug Code directory
RESFRIOL D
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69729-323_0fe17f30-ec4a-8f4e-e063-6294a90a1801
- Product NDC
- 69729-323
- Form
- TABLET
- Composition / generic term
- Acetaminophen, Chlorpheniramine Maleate, Phenylephrine HCl
- Labeler
- OPMX LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20240110
- Source listing expiry
- 20261231
Source-listed ingredients
- PHENYLEPHRINE HYDROCHLORIDE — 10 mg/1
- ACETAMINOPHEN — 500 mg/1
- CHLORPHENIRAMINE MALEATE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TABLET in 1 POUCH (69729-323-27) · 69729-323-27
- 6 POUCH in 1 CARTON (69729-323-37) / 2 TABLET in 1 POUCH · 69729-323-37
- 72 POUCH in 1 CARTON (69729-323-38) / 2 TABLET in 1 POUCH · 69729-323-38
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →